High-dose therapy for primary CNS lymphoma

Stefan Hohaus

doi:10.1016/S2352-3026(16)30060-6

High-dose therapy for primary CNS lymphoma

Stefan Hohaus

Research output: Contribution to journal › Editorial › peer-review

1 Citation (Scopus)

Abstract

N/A

Original language	English
Pages (from-to)	e359-e360
Journal	THE LANCET. HAEMATOLOGY
Volume	3
DOIs	https://doi.org/10.1016/S2352-3026(16)30060-6
Publication status	Published - 2016

Keywords

CNS lymphoma

Access to Document

10.1016/S2352-3026(16)30060-6

Cite this

@article{68f1697819754b048f2ff090043d9cba,

title = "High-dose therapy for primary CNS lymphoma",

abstract = "N/A",

keywords = "CNS lymphoma, CNS lymphoma",

author = "Stefan Hohaus",

year = "2016",

doi = "10.1016/S2352-3026(16)30060-6",

language = "English",

volume = "3",

pages = "e359--e360",

journal = "THE LANCET. HAEMATOLOGY",

issn = "2352-3026",

publisher = "Oxford : Elsevier",

}

TY - JOUR

T1 - High-dose therapy for primary CNS lymphoma

AU - Hohaus, Stefan

PY - 2016

Y1 - 2016

N2 - N/A

AB - N/A

KW - CNS lymphoma

UR - http://hdl.handle.net/10807/94772

UR - http://www.journals.elsevier.com/the-lancet-haematology/

U2 - 10.1016/S2352-3026(16)30060-6

DO - 10.1016/S2352-3026(16)30060-6

M3 - Editorial

SN - 2352-3026

VL - 3

SP - e359-e360

JO - THE LANCET. HAEMATOLOGY

JF - THE LANCET. HAEMATOLOGY

ER -

High-dose therapy for primary CNS lymphoma

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this